Futao Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Futao Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Bing Zhang
Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
2 shared publicationsQian Chen
Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
2 shared publicationsXiang Fan
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
2 shared publications- Bing Zhang
Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China
1 shared publication - Cong Long1 shared publication
- Jakub Hort
Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
1 shared publication
Latest Publications
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098138
Dynamic Functional Connectivity Changes in Subjective Cognitive Decline and Their Association with Spatial Navigation: A 5.0Tesla Ultra‐High Spatiotemporal Resolution fMRI Study
Background: Subjective cognitive decline (SCD) is considered the optimal window for early diagnosis and intervention in Alzheimer's disease (AD). SCD show changes in dynamic functional connectivity (DFC). Spatial navigation dysfunction is a sensitive biomarker for identifying SCD. However, the relationship between spatial navigation and DFC changes in the SCD is unclear. Ultra‐high field magnetic resonance imaging (HUF‐MRI) provides ultra‐high spatiotemporal resolution fMRI, making it possible to explore subtle functional changes in the brain in SCD. This study aimed to investigate the characteristics of DFC changes in SCD and their relationship with spatial navigation function and cognitive performance using 5.0T ultra‐high spatiotemporal resolution fMRI. Method: A total of 49 normal control (NC) participants and 46 individuals with SCD were recruited for comprehensive neuropsychological assessments, spatial navigation behavioral tests, plasma biomarker analysis, and ultra‐high spatiotemporal resolution fMRI scanning. Based on the sliding window method and k‐means clustering, distinct DFC states were identified. The number of windows, mean dwell time, and the number of transitions between each pair of DFC states were calculated. Finally, partial correlation analysis was used to assess the relationship between the temporal properties of DFC and spatial navigation function and cognitive performance. Result: Four distinct connectivity states were identified. Compared to NC, SCD exhibited more windows and longer mean dwell times in state 3, characterized by low connectivity both within and between networks. In contrast, in state 3, the SCD group showed fewer windows and shorter mean dwell times, dominated by high connectivity within the visual network and between the sensorimotor network, visual network, and attention network. Additionally, the number of transitions between state 2‐3 was significantly reduced in the SCD group. Correlation analysis indicated significant associations between DFC temporal properties with spatial navigation function and cognitive performance. Conclusion: The findings of this study suggest that ultra‐high spatiotemporal resolution fMRI using 5.0T MRI is an effective tool for investigating DFC changes in SCD. Alterations in DFC temporal properties in the SCD population may underlie early impairments in spatial navigation functions and can serve as sensitive neuroimaging biomarkers for the preclinical detection of AD.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098138
Open AccessDynamic Functional Connectivity Changes in Subjective Cognitive Decline and Their Association with Spatial Navigation: A 5.0Tesla Ultra‐High Spatiotemporal Resolution fMRI Study
Background: Subjective cognitive decline (SCD) is considered the optimal window for early diagnosis and intervention in Alzheimer's disease (AD). SCD show changes in dynamic functional connectivity (DFC). Spatial navigation dysfunction is a sensitive biomarker for identifying SCD. However, the relationship between spatial navigation and DFC changes in the SCD is unclear. Ultra‐high field magnetic resonance imaging (HUF‐MRI) provides ultra‐high spatiotemporal resolution fMRI, making it possible to explore subtle functional changes in the brain in SCD. This study aimed to investigate the characteristics of DFC changes in SCD and their relationship with spatial navigation function and cognitive performance using 5.0T ultra‐high spatiotemporal resolution fMRI. Method: A total of 49 normal control (NC) participants and 46 individuals with SCD were recruited for comprehensive neuropsychological assessments, spatial navigation behavioral tests, plasma biomarker analysis, and ultra‐high spatiotemporal resolution fMRI scanning. Based on the sliding window method and k‐means clustering, distinct DFC states were identified. The number of windows, mean dwell time, and the number of transitions between each pair of DFC states were calculated. Finally, partial correlation analysis was used to assess the relationship between the temporal properties of DFC and spatial navigation function and cognitive performance. Result: Four distinct connectivity states were identified. Compared to NC, SCD exhibited more windows and longer mean dwell times in state 3, characterized by low connectivity both within and between networks. In contrast, in state 3, the SCD group showed fewer windows and shorter mean dwell times, dominated by high connectivity within the visual network and between the sensorimotor network, visual network, and attention network. Additionally, the number of transitions between state 2‐3 was significantly reduced in the SCD group. Correlation analysis indicated significant associations between DFC temporal properties with spatial navigation function and cognitive performance. Conclusion: The findings of this study suggest that ultra‐high spatiotemporal resolution fMRI using 5.0T MRI is an effective tool for investigating DFC changes in SCD. Alterations in DFC temporal properties in the SCD population may underlie early impairments in spatial navigation functions and can serve as sensitive neuroimaging biomarkers for the preclinical detection of AD.
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098139
Glymphatic Dysfunction Correlate with Spatial Navigation Deficits in Subjective Cognitive Decline: Insights from 5.0T MRI and Plasma Biomarkers Analysis
Background: Glymphatic system dysfunction is implicated in cognitive impairments in Alzheimer's Disease (AD), particularly in early symptomatic stages like subjective cognitive decline (SCD). The link between glymphatic function and spatial navigation, a key early symptom, is not well‐understood. This study evaluates glymphatic function in SCD individuals through diffusion tensor image analysis of the perivascular space (DTI‐ALPS) and choroid plexus volume (CPV) measurements, and explores their relationship with spatial navigation abilities using ultra‐high‐field 5.0T MRI. Method: From May 2023 to January 2024, 62 SCD patients and 62 matched controls underwent 5.0T MRI, spatial navigation tests, cognitive evaluations, and plasma biomarker analyses. We used the ALPS index from DTI data and CPV from 3DT1WI to assess glymphatic function, analyzing these data alongside spatial and cognitive metrics using MANOVA, partial correlation, multiple regression, and mediation analysis. Result: The SCD group exhibited significant spatial navigation deficits and glymphatic dysfunction, characterized by lower ALPS indices and higher CPV compared to controls. Glymphatic measures correlated with navigation errors, with regression analysis highlighting predictive relationships between DTI‐ALPS, CPV, and navigation performance. Mediation analysis confirmed the ALPS index's role in linking CPV to spatial navigation deficits. Conclusion: Glymphatic dysfunction correlates with impaired spatial navigation in early SCD, suggesting its potential as a physiological marker for early AD diagnosis.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098139
Open AccessGlymphatic Dysfunction Correlate with Spatial Navigation Deficits in Subjective Cognitive Decline: Insights from 5.0T MRI and Plasma Biomarkers Analysis
Background: Glymphatic system dysfunction is implicated in cognitive impairments in Alzheimer's Disease (AD), particularly in early symptomatic stages like subjective cognitive decline (SCD). The link between glymphatic function and spatial navigation, a key early symptom, is not well‐understood. This study evaluates glymphatic function in SCD individuals through diffusion tensor image analysis of the perivascular space (DTI‐ALPS) and choroid plexus volume (CPV) measurements, and explores their relationship with spatial navigation abilities using ultra‐high‐field 5.0T MRI. Method: From May 2023 to January 2024, 62 SCD patients and 62 matched controls underwent 5.0T MRI, spatial navigation tests, cognitive evaluations, and plasma biomarker analyses. We used the ALPS index from DTI data and CPV from 3DT1WI to assess glymphatic function, analyzing these data alongside spatial and cognitive metrics using MANOVA, partial correlation, multiple regression, and mediation analysis. Result: The SCD group exhibited significant spatial navigation deficits and glymphatic dysfunction, characterized by lower ALPS indices and higher CPV compared to controls. Glymphatic measures correlated with navigation errors, with regression analysis highlighting predictive relationships between DTI‐ALPS, CPV, and navigation performance. Mediation analysis confirmed the ALPS index's role in linking CPV to spatial navigation deficits. Conclusion: Glymphatic dysfunction correlates with impaired spatial navigation in early SCD, suggesting its potential as a physiological marker for early AD diagnosis.
- Open Access
- 30 August 2022
- Published by AccScience Publishing in Advanced Neurology
- Vol. 1 (2) , 145
Neuroimaging associations with spatial navigation impairment in Alzheimer’s disease continuum: A narrative review
Identifying individuals with incipient Alzheimer’s disease (AD) are critical for early and targeted intervention before the dementia develops as AD progresses. Recently, emerging data have suggested that spatial navigation and neuroimaging could be utilized to identify individuals with prodromal AD. Compared to episodic memory, spatial navigation has fewer cultural and educational discrepancies and could serve as a promising marker for diagnosis and outcome measures in multicenter longitudinal studies with large cohorts. Furthermore, neuroimaging studies have contributed to our understanding of the structural and functional neural basis underlying spatial navigation and provided sensitive and non-invasive neuroimaging markers. The current review summarizes neuroimaging associations with spatial navigation impairment in the AD continuum, their potential pathophysiological mechanisms, and nonpharmacological interventions for spatial navigation impairments. We highlight the promising role of spatial navigation in the early identification of the preclinical and prodromal patients with potential risk of developing AD dementia. Multicenter large-scale longitudinal studies on patients across the AD continuum coupled with a standardized routine assessment of spatial navigation abilities in clinical settings are needed. This review may have implications for clinical practice and future research directions.
- 30 August 2022
- Published by AccScience Publishing in Advanced Neurology
- Vol. 1 (2) , 145
Open AccessNeuroimaging associations with spatial navigation impairment in Alzheimer’s disease continuum: A narrative review
Identifying individuals with incipient Alzheimer’s disease (AD) are critical for early and targeted intervention before the dementia develops as AD progresses. Recently, emerging data have suggested that spatial navigation and neuroimaging could be utilized to identify individuals with prodromal AD. Compared to episodic memory, spatial navigation has fewer cultural and educational discrepancies and could serve as a promising marker for diagnosis and outcome measures in multicenter longitudinal studies with large cohorts. Furthermore, neuroimaging studies have contributed to our understanding of the structural and functional neural basis underlying spatial navigation and provided sensitive and non-invasive neuroimaging markers. The current review summarizes neuroimaging associations with spatial navigation impairment in the AD continuum, their potential pathophysiological mechanisms, and nonpharmacological interventions for spatial navigation impairments. We highlight the promising role of spatial navigation in the early identification of the preclinical and prodromal patients with potential risk of developing AD dementia. Multicenter large-scale longitudinal studies on patients across the AD continuum coupled with a standardized routine assessment of spatial navigation abilities in clinical settings are needed. This review may have implications for clinical practice and future research directions.